LAKYNN BURRIS: Open Payments
NPI 1417515727 · ARKANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$89 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $89
Food & beverage: $89
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REXULTI, FANAPT, XIFAXAN, CAPLYTA, BREZTRI.
Industry payments across KS — which companies pay providers there.
